Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-394-9 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 27 January 1994 to 10 February 1994
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 994
- Report date:
- 1994
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- Version / remarks:
- Commission Directive 92/69/EEC
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- fixed dose procedure
- Limit test:
- yes
Test material
- Reference substance name:
- Fatty acids, C12-18, α-sulfo, 1-Me esters, sodium salts
- EC Number:
- 288-224-7
- EC Name:
- Fatty acids, C12-18, α-sulfo, 1-Me esters, sodium salts
- Cas Number:
- 85681-86-3
- Molecular formula:
- C13H25NaO5S - C19H37NaO5S
- IUPAC Name:
- Fatty acids, C12-18, α-sulfo, 1-Me esters, sodium salts
- Reference substance name:
- Fatty acids, C12-18, α-sulfo, disodium salts
- EC Number:
- 286-085-7
- EC Name:
- Fatty acids, C12-18, α-sulfo, disodium salts
- Cas Number:
- 85186-99-8
- Molecular formula:
- C12H22Na2O5S - C18H34Na2O5S
- IUPAC Name:
- Fatty acids, C12-18,α-sulfo, disodium salts
Constituent 1
Constituent 2
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- SPECIFICATION
- Five male and five female Sprague-Dawley rats were supplied by Harlan UK Ltd, Blackthorn, Bicester, Oxon, UK.
- At the start of the study animals were 213-234 g (males) or 210-232 g (females) and were 10-14 weeks old.
- After an acclimatisation period of at least 5 days, animals were selected at random and given a number unique within the study by indelible ink-marking on the tail and recording of the number on a cage card.
HUSBANDRY
- Animals were housed in suspended solid-floor polypropylene cages furnished with woodflakes.
- Animals were housed individually during the 24-hour exposure period and in groups of five, by sex, for the remainder of the study.
- Free access to mains drinking water and food (Rat and Mouse Expanded Diet No 1, Special Diets Services Limited, Witham, Essex, UK) was allowed during the study.
- The animal room was maintained at a temperature of 19 to 22 °C and humidity of 30 to 51 %.
- Rate of air exchange was approximately 15 changes per hour.
- Lighting was controlled by a time switch to give 12 hours continuous light and 12 hours darkness.
Administration / exposure
- Type of coverage:
- semiocclusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- PROCEDURE
- On the day before treatment, the back and flanks of each animal were clipped free of hair using veterinary clippers to expose a skin area of approximately 5 cm x 4 cm.
- Five male and five female rats were treated with the test item at a dose level of 2000 mg/kg.
- The appropriate amount of the test material (as received) was pre-weighed into a glass vial.
- Test material was applied uniformly to an area of shorn skin (approximating to 10 % of the total body surface area) which had been previously moistened with distilled water.
- A piece of surgical gauze measuring 7 cm x 4 cm was placed over the treatment area and semi-occluded with a piece of self-adhesive bandage (HYPERTIE). The bandage was further secured with a piece of BLENDERM wrapped around each end.
- The animals were caged individually for the 24-hour exposure period.
- Shortly after dosing the dressings were examined to ensure they were securely in place.
- After the 24 hour contact period the bandage was carefully removed and the treated skin and surrounding hair wiped with cotton wool moistened with distilled water to remove any residual test item.
- Animals were returned to group housing for the remainder of the test period.
- Test sites were examined for evidence of primary irritation and scored according to the Draize evaluation scheme (attached).
- Animals were observed for deaths or overt signs of toxicity at 0.5, 1, 2 and 4 hours after dosing then once daily for the subsequent 14 days.
- The animals were also observed for any dermal reactions after removal of the dressings and subsequently once daily for the remainder of the study.
- Individual bodyweights were recorded prior to application of the test material on Day 0 and on Days 7 and 14.
- At the end of the study the animals were killed by cervical dislocation and subjected to gross pathological examination. This consisted of an external examination and opening of the abdominal and thoracic cavities. The appearance of any macroscopic abnormalities was recorded. No tissues were retained. - Duration of exposure:
- 24 hours
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- Five male and five female
- Control animals:
- no
- Statistics:
- EVALUATION OF DATA
- Data evaluations included any relationship between exposure of animals to the test material and the incidence and severity of all abnormalities including behavioural and clinical observations, gross lesions, bodyweight changes, mortality and any other toxicological effects.
- Using the mortality data obtained, an estimate of the acute dermal median lethal dose (LD50) of the test material was made.
Results and discussion
Effect levels
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- - No animal deaths took place during the study.
- Mortality data is given in Table 1 (attached). - Clinical signs:
- other: - No signs of systemic toxicity were noted during the study. - Individual clinical observations are given in Table 1 (attached).
- Gross pathology:
- - No abnormalities were noted at necropsy.
- Individual necropsy findings are given in Table 4 (attached). - Other findings:
- DERMAL REACTIONS
- Very slight to well-defined erythema was noted at the treatment sites of all animals.
- Very slight oedema was noted at the treatment sites of two males.
- Desquamation and/or slight haemorrhage of dermal capillaries was noted at the treatment sites of three animals.
- Loss of skin elasticity was confined to one male.
- Treatment sites appeared normal three to seven days after dosing.
- Individual dermal reactions are given in Table 2 (attached).
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The acute dermal median lethal dose (LD50) of the test material in the Sprague-Dawley rat was determined to be > 2000 mg/kg bw.
- Executive summary:
A study was performed in accordance with OECD 402 and EU Method B.3 to assess the acute dermal toxicity of the test material in Sprague-Dawley rats. A group of ten animals (five males and five females) was given a single 24 -hour semi-occluded dermal application of test material to intact skin at a dose level of 2000 mg/kg bw. The animals were observed for fourteen days after the day of treatment and were then killed for gross pathological examination. No animal deaths took place during the study. No signs of systemic toxicity were noted and signs of skin irritation were very slight to well-defined erythema, very slight oedema, slight haemorrhage of dermal capillaries, desquamation and loss of skin elasticity. The treatment sites appeared normal 3 to 7 days after dosing. All animals showed expected gain in bodyweight during the study except for one female which showed bodyweight loss during the first week and expected bodyweight gain during the second week. No abnormalities were noted at necropsy. The acute dermal median lethal dose (LD50) of the test material in the Sprague-Dawley rat was determined to be > 2000 mg/kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.